Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Large Cap Fund median (41 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 100 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | SBI Large Cap Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹131.11 |
| 26 Aug 2009 | ₹100.91 |
| 08 May 2011 | ₹101.46 |
| 17 Jan 2013 | ₹121.59 |
| 30 Sep 2014 | ₹154.64 |
| 11 Jun 2016 | ₹163.67 |
| 21 Feb 2018 | ₹193.79 |
| 04 Nov 2019 | ₹214.81 |
| 16 Jul 2021 | ₹293.30 |
| 28 Mar 2023 | ₹315.00 |
| 08 Dec 2024 | ₹474.37 |
| 20 Aug 2026 | ₹489.33 |
| Metric | SBI · Regular · IDCW NAV ₹53.48 Very High risk ★★★★★ | Category median Large Cap Fund · 41 funds |
|---|---|---|
| +1.31% | -5.49% | |
| +10.42% | +7.73% | |
| +10.51% | +6.21% | |
| +10.82% | +4.02% | |
| +8.10% | +5.54% | |
| +9.32% | — | |
| +9.73% | +6.92% | |
| +9.64% | +6.12% | |
| +9.48% | +3.99% | |
| Risk | ||
| 12.45% | 14.74% | |
| 0.32 | 0.02 | |
| 0.44 | 0.03 | |
| -63.89% | -48.01% | |
| Nifty 100 | — | |
| +0.53% | -1.74% | |
| 0.92 | 0.98 | |
| 92.7% | 93.8% | |
| 85.9% | 102.3% | |
| 1.50% | 2.38% | |
| ₹52,232Cr | ₹1,495Cr | |
| Up to 0.25% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 8% | 58% | |
| Pradeep Kesavan · 2.7y | — | |
| 03 Apr 2006 | — | |
| 53 | — | |
| 48.3% | — | |
| 0.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.